rs138087806
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 6P and 5B. PM1PM2PM5BP4_StrongBP6
The ENST00000307340.8(USH2A):c.8575C>T(p.Arg2859Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000189 in 1,613,630 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2859H) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000307340.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.8575C>T | p.Arg2859Cys | missense_variant | 43/72 | ENST00000307340.8 | NP_996816.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.8575C>T | p.Arg2859Cys | missense_variant | 43/72 | 1 | NM_206933.4 | ENSP00000305941 | P1 | |
USH2A | ENST00000674083.1 | c.8575C>T | p.Arg2859Cys | missense_variant | 43/73 | ENSP00000501296 |
Frequencies
GnomAD3 genomes AF: 0.000579 AC: 88AN: 152036Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000303 AC: 76AN: 251146Hom.: 0 AF XY: 0.000302 AC XY: 41AN XY: 135722
GnomAD4 exome AF: 0.000148 AC: 216AN: 1461476Hom.: 0 Cov.: 32 AF XY: 0.000132 AC XY: 96AN XY: 727040
GnomAD4 genome AF: 0.000585 AC: 89AN: 152154Hom.: 1 Cov.: 32 AF XY: 0.000592 AC XY: 44AN XY: 74378
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 28, 2020 | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31054281) - |
Uncertain significance, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
not specified Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 15, 2010 | Arg2859Cys in exon 43 of USH2A: This variant is not expected to have clinical si gnificance because it is not conserved in mammals with a cysteine residue in mou se and cow. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 29, 2022 | Variant summary: USH2A c.8575C>T (p.Arg2859Cys) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0003 in 251146 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in USH2A causing Usher Syndrome (0.0003 vs 0.011), allowing no conclusion about variant significance. c.8575C>T has been reported in the literature as a VUS in heterozygous individuals affected with Usher Syndrome, inherited retinal disease, and hearing impairment, without strong evidence for causality (e.g. Besnard_2014, Gao_2021, Wonkam_2021). These reports do not provide unequivocal conclusions about association of the variant with Usher Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. One laboratory classified the variant as likely benign, and one laboratory classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
USH2A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 06, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at